172 related articles for article (PubMed ID: 34782396)
21. Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.
Picó MD; Sánchez-Heras AB; Castillejo A; Giner-Calabuig M; Alustiza M; Sánchez A; Moreira L; Pellise M; Castells A; Llort G; Yagüe C; Ramon Y Cajal T; Gisbert-Beamud A; Cubiella J; Rivas L; Herraiz M; Garau C; Salces I; Carrillo-Palau M; Bujanda L; López-Fernández A; Alvarez-Urturi C; López MJ; Alenda C; Zapater P; Lacueva FJ; Balaguer F; Soto JL; Murcia Ó; Jover R
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784934
[TBL] [Abstract][Full Text] [Related]
22. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
Cannon-Albright LA; Carr SR; Akerley W
J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
[TBL] [Abstract][Full Text] [Related]
23. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model.
Pandharipande PV; Jeon A; Heberle CR; Dowling EC; Kong CY; Chung DC; Brugge WR; Hur C
EBioMedicine; 2015 Dec; 2(12):1980-6. PubMed ID: 26844277
[TBL] [Abstract][Full Text] [Related]
24. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.
Egawa N; Lin Y; Tabata T; Kuruma S; Hara S; Kubota K; Kamisawa T
World J Gastroenterol; 2013 Apr; 19(16):2537-42. PubMed ID: 23674856
[TBL] [Abstract][Full Text] [Related]
25. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
Alegre N; Perre PV; Bignon YJ; Michel A; Galibert V; Mophawe O; Corsini C; Coupier I; Chiesa J; Robert L; Bernhard L; Picot MC; Bertet H; Macioce V; Bastide N; Solassol J; Rey JM; Thomas F; Carton S; Pujol P
Psychooncology; 2019 Aug; 28(8):1679-1686. PubMed ID: 31152683
[TBL] [Abstract][Full Text] [Related]
26. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China.
Jia WH; Feng BJ; Xu ZL; Zhang XS; Huang P; Huang LX; Yu XJ; Feng QS; Yao MH; Shugart YY; Zeng YX
Cancer; 2004 Jul; 101(2):363-9. PubMed ID: 15241835
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
[TBL] [Abstract][Full Text] [Related]
28. Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.
Mocci E; Milne RL; Méndez-Villamil EY; Hopper JL; John EM; Andrulis IL; Chung WK; Daly M; Buys SS; Malats N; Goldgar DE
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):803-11. PubMed ID: 23456555
[TBL] [Abstract][Full Text] [Related]
29. Importance of age of onset in pancreatic cancer kindreds.
Brune KA; Lau B; Palmisano E; Canto M; Goggins MG; Hruban RH; Klein AP
J Natl Cancer Inst; 2010 Jan; 102(2):119-26. PubMed ID: 20068195
[TBL] [Abstract][Full Text] [Related]
30. Population-based relative risks for specific family history constellations of breast cancer.
Albright FS; Kohlmann W; Neumayer L; Buys SS; Matsen CB; Kaphingst KA; Cannon-Albright LA
Cancer Causes Control; 2019 Jun; 30(6):581-590. PubMed ID: 31030355
[TBL] [Abstract][Full Text] [Related]
31. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Li D; Pise MN; Overman MJ; Liu C; Tang H; Vadhan-Raj S; Abbruzzese JL
Cancer Med; 2015 Nov; 4(11):1651-8. PubMed ID: 26275671
[TBL] [Abstract][Full Text] [Related]
32. ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous Neoplasms.
Hamada T; Oyama H; Nakai Y; Tada M; Koh H; Tateishi K; Arita J; Hakuta R; Ijichi H; Ishigaki K; Kawaguchi Y; Kogure H; Mizuno S; Morikawa T; Saito K; Saito T; Sato T; Takagi K; Takahara N; Takahashi R; Tanaka A; Tanaka M; Ushiku T; Hasegawa K; Koike K
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):1020-1028. PubMed ID: 33653811
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer genetic epidemiology consortium.
Petersen GM; de Andrade M; Goggins M; Hruban RH; Bondy M; Korczak JF; Gallinger S; Lynch HT; Syngal S; Rabe KG; Seminara D; Klein AP
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):704-10. PubMed ID: 16614112
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.
Stadler ZK; Salo-Mullen E; Patil SM; Pietanza MC; Vijai J; Saloustros E; Hansen NA; Kauff ND; Kurtz RC; Kelsen DP; Offit K; Robson ME
Cancer; 2012 Jan; 118(2):493-9. PubMed ID: 21598239
[TBL] [Abstract][Full Text] [Related]
35. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
[TBL] [Abstract][Full Text] [Related]
36. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
Rizzato C; Campa D; Pezzilli R; Soucek P; Greenhalf W; Capurso G; Talar-Wojnarowska R; Heller A; Jamroziak K; Khaw KT; Key TJ; Bambi F; Landi S; Mohelnikova-Duchonova B; Vodickova L; Büchler MW; Bugert P; Vodicka P; Neoptolemos JP; Werner J; Hoheisel JD; Bauer AS; Giese N; Canzian F
Oncol Rep; 2013 Apr; 29(4):1637-44. PubMed ID: 23403949
[TBL] [Abstract][Full Text] [Related]
37. Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model.
Peters MLB; Eckel A; Lietz A; Seguin C; Mueller P; Hur C; Pandharipande PV
Pancreatology; 2022 Sep; 22(6):760-769. PubMed ID: 35752568
[TBL] [Abstract][Full Text] [Related]
38. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
Zhen DB; Rabe KG; Gallinger S; Syngal S; Schwartz AG; Goggins MG; Hruban RH; Cote ML; McWilliams RR; Roberts NJ; Cannon-Albright LA; Li D; Moyes K; Wenstrup RJ; Hartman AR; Seminara D; Klein AP; Petersen GM
Genet Med; 2015 Jul; 17(7):569-77. PubMed ID: 25356972
[TBL] [Abstract][Full Text] [Related]
39. Comparative Analysis of Glaucoma Screening Uptake Among First-Degree Relatives After Community-Based and Hospital-Based Approaches.
Nitikarun P; Kongsap P
Clin Ophthalmol; 2024; 18():1563-1573. PubMed ID: 38832077
[TBL] [Abstract][Full Text] [Related]
40. Population-based family history-specific risks for colorectal cancer: a constellation approach.
Taylor DP; Burt RW; Williams MS; Haug PJ; Cannon-Albright LA
Gastroenterology; 2010 Mar; 138(3):877-85. PubMed ID: 19932107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
